1-4 of 4
Apostolia M. Tsimberidou
Close
Sort by
Journal Articles

Untreated Patients with Acute Myeloid Leukemia, Age 50–59 Years and Performance Status 2 Should Be as Eligible for Targeted Therapy as Older Patients.

Apostolia M. Tsimberidou, MD, PhD, Hagop M. Kantarjian, MD, Stefan Faderl, MD, Sherry Pierce, RN, Emil J. Freireich, MD, Elihu Estey, MD
Journal: Blood
Blood (2007) 110 (11): 2864.
https://doi.org/10.1182/blood.V110.11.2864.2864
Published: 2007
Journal Articles

The Clinical Usefulness of Novel Prognostic Factors in CLL: A Study of 477 Patients with Low-Risk (Non-11q, Non-17p) FISH and Known IGVH Mutation Status.

Constantine S. Tam, MBBS, Michael J. Keating, MD, Apostolia M. Tsimberidou, MD, Susan O’Brien, MD, Alessandra Tsimberidou, MD, Susan Lerner, MS, Lynne Abruzzo, MD, Ellen Schlette, MD, Hagop Kantarjian, MD, William Wierda, MD
Journal: Blood
Blood (2007) 110 (11): 3079.
https://doi.org/10.1182/blood.V110.11.3079.3079
Published: 2007
Journal Articles

Potential curability of newly diagnosed acute promyelocytic leukemia without use of chemotherapy: the example of liposomal all- trans retinoic acid

Elihu Estey, Charles Koller, Apostolia M. Tsimberidou, Susan O'Brien, Miloslav Beran, Jorge Cortes, Maribel Tirado-Gomez, Gabriel Lopez-Berestein, Hagop Kantarjian
Journal: Blood
Blood (2005) 105 (3): 1366–1367.
https://doi.org/10.1182/blood-2004-09-3437
Published: 2005
Journal Articles

Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma

Clinical Trials & Observations
Apostolia M. Tsimberidou, Peter McLaughlin, Anas Younes, Maria A. Rodriguez, Fredrick B. Hagemeister, Andreas Sarris, Jorge Romaguera, Mark Hess, Terry L. Smith, Ying Yang, Ana Ayala, Alejandro Preti, Ming-Sheng Lee, Fernando Cabanillas
Journal: Blood
Blood (2002) 100 (13): 4351–4357.
https://doi.org/10.1182/blood-2001-12-0269
Published: 2002